Hyperinfection typically occurs in people who have impaired Th2 type cell-mediated immunity including those taking corticosteroids or immunosuppressive biologics, receiving immunosuppressive therapy for solid organ or hematopoietic stem cell transplants, or infected with the human T-lymphotropic virus 1 (HTLV-1).